IL1B and heavy chain disease: Nevertheless, we used our novel MO-delivery approach to target IL-1β using a previously validated MO and found that knockdown resulted in abrogation of the accumulation in L-Plastin+ cells in the intestine (Fig. 4g), suggesting that this cytokine is involved in HCD-induced intestinal inflammation.